Key result
Electrocardiographic imaging metrics distinguish ischemic cardiomyopathy and prior arrhythmia patients from healthy controls.
Why the study?
Sudden cardiac death from ventricular arrhythmias is the leading cause of death in ischemic cardiomyopathy, making accurate arrhythmic risk assessment vital for preventive measures.
Can electrocardiographic imaging (ECGi) metrics predict the risk of ventricular arrhythmias in patients with ischemic cardiomyopathy?
Systematic Review
Can electrocardiographic imaging (ECGi) metrics predict the risk of ventricular arrhythmias in patients with ischemic cardiomyopathy?
ECGi provides non-invasive metrics that can distinguish patients with ischemic cardiomyopathy at increased risk for ventricular arrhythmias, though prospective validation is needed.
Answers are grounded in this paper and cite their sources.
May aid noninvasive risk stratification in ischemic cardiomyopathy; leaves open prospective validation for arrhythmia prediction.
Background: The leading cause of death in patients with ischemic cardiomyopathy is sudden cardiac death caused by ventricular arrhythmias. Accurate determination of arrhythmic risk in these patients is vital to allow clinicians to take appropriate preventive measures. Objective: To review and summarize the literature on electrocardiographic imaging (ECGi) metrics that could be used to predict arrhythmic risk in patients with ischemic cardiomyopathy. Methods: A comprehensive literature search was performed to retrieve research articles on non-invasive electrocardiographic mapping techniques. Inclusion criteria of the studies required the involvement of patients with ischemic cardiomyopathy or ischemic heart disease. Results: A total of 17 papers were identified, five of which specifically utilized ECGi to acquire metrics associated with an increased risk of ventricular arrhythmia (VA). ECGi metrics, including activation time, repolarization time, activation-recovery interval, and voltage amplitude, were distinguishable between patients with ischemic cardiomyopathy, patients with a history of VA, and healthy controls. Conclusion: ECGi allows non-invasive measurement of metrics which are associated with an increased risk of ventricular arrhythmias in patients with ischemic cardiomyopathy. ECGi may be a useful tool for risk assessment in these patients. Prospective studies are warranted for further validation and prediction of clinical endpoints.
No takes yet. Share an insight, caveat, or question.
Ardinal et al. (2025) conducted a systematic review in Ischemic cardiomyopathy. Electrocardiographic imaging (ECGi) vs. Healthy controls or patients without history of ventricular arrhythmia was evaluated on Metrics associated with an increased risk of ventricular arrhythmia. Electrocardiographic imaging metrics, including activation and repolarization times, were distinguishable between ischemic cardiomyopathy patients, those with prior arrhythmias, and healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: